Fallowfield, Jonathan A.

Baveno VII – Renewing consensus in portal hypertension

de Franchis, R., Bosch, J., Garcia-Tsao, G., Reiberger, T., Ripoll, C., Abraldes, J. G., Albillos, A., Baiges, A., Bajaj, J., Bañares, R., et al. (2022) · Journal of Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 2,930

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature

Liver physiology and pathologyLiver Diseases and Immunity

Cited by 1,784

Liver fibrosis and repair: Immune regulation of wound healing in a solid organ

Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology

Liver physiology and pathologyWound Healing and Treatments

Cited by 1,310

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences

Liver physiology and pathologyCardiac Fibrosis and Remodeling

Cited by 1,001

Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes

Poole, R., Kennedy, O. J., Roderick, P., Fallowfield, J. A., Hayes, P. C., & Parkes, J. (2017) · BMJ

Coffee research and impactsAlcohol Consumption and Health Effects

Cited by 835

Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis

Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., & Iredale, J. P. (2007) · The Journal of Immunology

Liver physiology and pathologyCardiac Fibrosis and Remodeling

Cited by 479

Safety profile of autologous macrophage therapy for liver cirrhosis

Moroni, F., Dwyer, B. J., Graham, C., Pass, C., Bailey, L., Ritchie, L., Mitchell, D., Glover, A., Laurie, A., Doig, S., et al. (2019) · Nature Medicine

Liver physiology and pathologyLiver Disease and Transplantation

Cited by 202

Clinical utility of magnetic resonance imaging biomarkers for identifying nonalcoholic steatohepatitis patients at high risk of progression: a multicenter pooled data and meta-analysis

Andersson, A., Kelly, M., Imajo, K., Nakajima, A., Fallowfield, J. A., Hirschfield, G., Pavlides, M., Sanyal, A. J., Noureddin, M., Banerjee, R., et al. (2022) · Clinical Gastroenterology and Hepatology

Liver Disease Diagnosis and TreatmentAdvanced MRI Techniques and Applications

Cited by 148

Hepatic stellate cells control liver zonation, size and functions via R-spondin 3

Sugimoto, A., Saito, Y., Wang, G., Sun, Q., Yin, C., Lee, K. H., Geng, Y., Rajbhandari, P., Hernandez, C., Steffani, M., et al. (2025) · Nature

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 133

Resolution of Liver Fibrosis: Basic Mechanisms and Clinical Relevance

Ramachandran, P., Iredale, J., & Fallowfield, J. (2015) · Seminars in Liver Disease

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 129

In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications

Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 127

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach

Brennan, P. N., Elsharkawy, A. M., Kendall, T. J., Loomba, R., Mann, D. A., & Fallowfield, J. A. (2023) · Nature Reviews Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 68

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine

Liver Disease and TransplantationLiver physiology and pathology

Cited by 66

All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study

Kennedy, O. J., Fallowfield, J. A., Poole, R., Hayes, P. C., Parkes, J., & Roderick, P. J. (2021) · BMC Public Health

Coffee research and impactsAlcohol Consumption and Health Effects

Cited by 58

Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease

Fallowfield, J. A. (2015) · Clinical Medicine

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 15

LBP-007 Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial

Brennan, P., Macpherson, I., Troland, D., Kilpatrick, A. M., Manship, T., McGowan, N., Campbell, J., Fraser, A., Pass, C., Moroni, F., et al. (2024) · Journal of Hepatology

Liver Disease and TransplantationLiver physiology and pathology

Cited by 3

P68 An open-label phase 1/2 multicentre study to evaluate the safety, tolerability and efficacy of RTX001 autologous macrophages in participants with liver cirrhosis who have hepatic decompensation (EMERALD)

Fallowfield, J., Thursz, M., Guha, N., Rodriguez-Peralvarez, M., Kitto, E., Sheikh, F., & Brass, C. (2025) · P68 An open-label phase 1/2 multicentre study to evaluate the safety, tolerability and efficacy of RTX001 autologous macrophages in participants with liver cirrhosis who have hepatic decompensation (EMERALD)

Liver Disease and TransplantationLiver physiology and pathology

Cited by 1